Latest Breaking News On - Astra zeneca chadox - Page 1 : comparemela.com
Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
science.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science.org Daily Mail and Mail on Sunday newspapers.
DCGI nod to study on mixing of Covishield, Covaxin: Sources
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.
WHO expert panel recommends using same vaccine for both doses
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.
E-Mail
A new study to be presented at this year s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) (9-12 July) and published this week in
The Lancet Infectious Diseases shows that, for residents of long-term care homes for adults aged 65 years and over, a single dose of either the Pfizer or Astra Zeneca COVID-19 vaccine offers around 60% protection against infection from SARS-CoV-2. The study is by Dr Madhumita Shrotri and Dr Laura Shallcross, UCL Institute of Health Informatics, University College London, UK, and colleagues.
The greatest effects of SARS-CoV-2 have been in residents of long-term care facilities, who represent a small fraction of the general population but account for a disproportionate number of SARS-CoV-2-related deaths in many countries, including the UK. As in other countries, the UK prioritised residents of these care homes to receive the first doses of COVID-19 vaccines that arrived in the country.